Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00517673 | To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects | PHASE1 | COMPLETED | 68 | — | — | Jul 1, 2007 | Sep 1, 2008 | Mar 19, 2012 | 1 | Australia |
| Arm | Type | Description |
|---|---|---|
| GSK945237 | EXPERIMENTAL | Active Study Drug |
| Sugar Pill | PLACEBO_COMPARATOR | Placebo |
| Name | Type | Description |
|---|---|---|
| GSK945237 | DRUG | - |
| Sugar Pill | DRUG | Placebo |
Inclusion Criteria: * Healthy male and female adults between 18 and 60 years of age. * Body weight proportional to height. * Female subjects must be of non-childbearing potential. * QTc less than 450 msec at screening Exclusion Criteria: * Any clinically relevant abnormality identified on the scr...